• Tue, October 10, 2023
Andreas Argyrides Reiterated (AQST) at Buy and Held Target at $4 on, Oct 10th, 2023
Andreas Argyrides of Wedbush, Reiterated "Aquestive Therapeutics, Inc." (AQST) at Buy and Held Target at $4 on, Oct 10th, 2023.
Andreas has made no other calls on AQST in the last 4 months.
There is 1 other peer that has a rating on AQST. Out of the 1 peers that are also analyzing AQST, 0 agree with Andreas's Rating of Hold.
This is the rating of the analyst that currently disagrees with Andreas
- Jason Butler of "JMP Securities" Reiterated at Buy and Held Target at $8 on, Thursday, September 21st, 2023
Like: 👍
